Maissa Ballout Shamshoum

Heinz Ventures is an operator-led early-stage medical technology investment firm founded in 2015 by Eric S. Heinz. We invest in pre-seed and seed-stage MedTech companies developing regulated products, with a focus on the U.S. Heartland. Our approach combines capital with more than 25 years of operating experience across medical device engineering, product development, commercialization, corporate development, M&A, and governance. Heinz Ventures works closely with founders and management teams on the issues that matter most in early-stage MedTech: product and regulatory strategy, commercialization, strategic partnerships, governance, financing, and positioning for future transactions. In addition to venture investing, Heinz Ventures selectively provides independent board, business development advisory, and medical device expert witness services. Our objective is simple: bring operator-level judgment to high-stakes decisions in regulated medical technology.

Madison Scientific, Inc. (MadSci™) is an early-stage medical device company innovating solutions to improve care for individuals with hydrocephalus. The company’s SmartShunt™ Hydrocephalus Management System is designed to be an integrated solution for enabling personalized and informed hydrocephalus management. It features state-of-the-art SmartValve™ technology.

An affiliated partner of the G20 - Global Partnership for Financial Inclusion (GPFI) chaired by Her Majesties Queean Maxima of the Netherlands, The World Business Angels Investment Forum (WBAF) is an international organisation aiming to ease access to finance for businesses from start up to scale up to exit, with the ultimate goal of generating more jobs and more social justice worldwide. It is committed to collaborating globally to empower world economic development by creating innovative financial instruments for innovators, startups, and SMEs. The Forum interacts with leaders in all areas of society, first and foremost in business and political spheres, to help assess needs and establish goals, bearing in mind that the public interest is of paramount importance. We engage a wide range of institutions, both public and private, local and international, commercial and academic to help shape the global agenda. We hold that, with the participation of individuals and institutions from multiple sectors and from all parts of society, real progress can be achieved. www.wbaforum.org

TimelyAI is building a Marketing Saas for Time-based Businesses. “The idea is to solve the most burning need of our customers- Growing their clientele at an affordable price and being able to build lasting relationships with them for repeat business and referrals.” "Coming soon with something extremely crazy!"

Heinz Ventures is an operator-led early-stage medical technology investment firm founded in 2015 by Eric S. Heinz. We invest in pre-seed and seed-stage MedTech companies developing regulated products, with a focus on the U.S. Heartland. Our approach combines capital with more than 25 years of operating experience across medical device engineering, product development, commercialization, corporate development, M&A, and governance. Heinz Ventures works closely with founders and management teams on the issues that matter most in early-stage MedTech: product and regulatory strategy, commercialization, strategic partnerships, governance, financing, and positioning for future transactions. In addition to venture investing, Heinz Ventures selectively provides independent board, business development advisory, and medical device expert witness services. Our objective is simple: bring operator-level judgment to high-stakes decisions in regulated medical technology.

Madison Scientific, Inc. (MadSci™) is an early-stage medical device company innovating solutions to improve care for individuals with hydrocephalus. The company’s SmartShunt™ Hydrocephalus Management System is designed to be an integrated solution for enabling personalized and informed hydrocephalus management. It features state-of-the-art SmartValve™ technology.